The U.S. Food and Drug Administration (FDA) has approved GSK’s Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with chronic obstructive pulmonary disease (COPD) with ...

Food allergies may range in severity for every individual but they are never something to ignore, even at the slightest […] ...

Discover a study that highlights a potentially critical role for the BDNF-NTRK2 pathway in EoE symptom development.

FDA approves mepolizumab (Nucala; GSK) as the first monthly biologic for chronic obstructive pulmonary disease (COPD), significantly reducing exacerbations in patients with an eosinophilic phenotype.

A later phase, driven by eosinophils, can cause the inflammation to last ... Eye itching, tearing and pain may also be present as well, and is called allergic conjunctivitis. Symptom timing, duration, ...

Dextenza is not recommended for treating ocular itching with allergic conjunctivitis in children who require sedation for the insertion procedure. The Food and Drug Administration (FDA ...

and prevents eosinophil accumulation. These multiple, pharmacological mechanisms provided the rationale for assessing the efficacy and safety of ketotifen 0.025% eye drops in subjects with seasonal ...

ODACTRA is now indicated to treat house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis ... any sublingual immunotherapy before has ever been diagnosed with eosinophilic ...

Yes, exposure to mold can trigger conjunctivitis. Specifically, mold is an environmental trigger that can result in allergic conjunctivitis. As the name suggests, this is a type of conjunctivitis ...

allergic conjunctivitis, IgE-mediated food allergy, atopic dermatitis, eosinophilic oesophagitis, and NSAID-exacerbated respiratory disease (NERD). Using this information, we propose a simple, patient ...